Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Adib Deyaa | Jun 12, 2024 | Buy | 22,123 | $1.17 | $26,000 |
| Wettig Thane | Mar 7, 2024 | Buy | 50,000 | $1.9094 | $95,000 |
| Henderson Jeffrey William | Sep 1, 2023 | Sell | 2,000 | $1.03 | $2,100 |
| Henderson Jeffrey William | Aug 4, 2023 | Sell | 2,000 | $1.91 | $3,800 |
| Henderson Jeffrey William | Jul 11, 2023 | Sell | 2,000 | $2.69 | $5,400 |
| Conterno Enrique A | Jul 7, 2023 | Sell | 1,880 | $2.8 | $5,300 |
| Chung Christine | Jun 14, 2023 | Sell | 5,250 | $16.66 | $87,000 |
| Chung Christine | Jun 14, 2023 | Sell | 1,000 | $17.46 | $17,000 |
| Chung Christine | Jun 13, 2023 | Sell | 6,250 | $17.6 | $110,000 |
| Cravatt Benjamin | Jun 9, 2023 | Sell | 2,178 | $17.51 | $38,000 |
| Cravatt Benjamin | Jun 9, 2023 | Sell | 1,766 | $16.75 | $30,000 |
| Brennan Aoife | Jun 9, 2023 | Sell | 2,739 | $17.52 | $48,000 |
| Brennan Aoife | Jun 9, 2023 | Sell | 1,994 | $16.74 | $33,000 |
| Blaug Suzanne | Jun 9, 2023 | Sell | 5,169 | $17.51 | $91,000 |
| Blaug Suzanne | Jun 9, 2023 | Sell | 3,351 | $16.73 | $56,000 |
| EDWARDS JEFFREY L | Jun 9, 2023 | Sell | 4,624 | $17.51 | $81,000 |
| EDWARDS JEFFREY L | Jun 9, 2023 | Sell | 3,265 | $16.74 | $55,000 |
| Ho Maykin | Jun 8, 2023 | Sell | 6,225 | $17.68 | $110,000 |
| Ho Maykin | Jun 8, 2023 | Sell | 2,295 | $16.79 | $39,000 |
| Henderson Jeffrey William | Jun 8, 2023 | Sell | 4,994 | $17.69 | $88,000 |
| Henderson Jeffrey William | Jun 8, 2023 | Sell | 2,006 | $16.87 | $34,000 |
| Wettig Thane | Jun 7, 2023 | Sell | 1,286 | $17.0377 | $22,000 |
| Schoeneck James A | Jun 7, 2023 | Sell | 7,100 | $18.0264 | $130,000 |
| Wettig Thane | Jun 7, 2023 | Sell | 1,286 | $17.0377 | $22,000 |
| Graham Juan | Jun 7, 2023 | Sell | 1,050 | $16.9494 | $18,000 |
| Chung Christine | Jun 7, 2023 | Sell | 1,532 | $17.0376 | $26,000 |
| Chung Christine | Jun 7, 2023 | Sell | 1,362 | $17.0353 | $23,000 |
| Eisner Mark | Jun 7, 2023 | Sell | 2,042 | $17.038 | $35,000 |
| Conterno Enrique A | Jun 7, 2023 | Sell | 6,106 | $17.0379 | $100,000 |
| Conterno Enrique A | Jun 7, 2023 | Sell | 2,791 | $17.0368 | $48,000 |
| Wettig Thane | Jun 7, 2023 | Sell | 472 | $17.0356 | $8,000 |
| Wettig Thane | Jun 7, 2023 | Sell | 472 | $17.0356 | $8,000 |
| Graham Juan | Jun 7, 2023 | Sell | 735 | $17.0383 | $13,000 |
| Chung Christine | Jun 7, 2023 | Sell | 739 | $17.0363 | $13,000 |
| Eisner Mark | Jun 2, 2023 | Sell | 1,090 | $18.83 | $21,000 |
| Conterno Enrique A | Apr 10, 2023 | Sell | 1,869 | $19.52 | $36,000 |
| Eisner Mark | Apr 4, 2023 | Sell | 9,182 | $18.7838 | $170,000 |
| Chung Christine | Apr 4, 2023 | Sell | 6,590 | $18.7838 | $120,000 |
| Wettig Thane | Mar 23, 2023 | Sell | 905 | $18.71 | $17,000 |
| Conterno Enrique A | Mar 10, 2023 | Sell | 19,486 | $20.1973 | $390,000 |
| Conterno Enrique A | Mar 10, 2023 | Sell | 12,103 | $20.1973 | $240,000 |
| Chung Christine | Mar 10, 2023 | Sell | 4,692 | $20.1973 | $95,000 |
| Chung Christine | Mar 10, 2023 | Sell | 2,914 | $20.1973 | $59,000 |
| Eisner Mark | Mar 10, 2023 | Sell | 6,255 | $20.1973 | $130,000 |
| Eisner Mark | Mar 10, 2023 | Sell | 3,885 | $20.1973 | $78,000 |
| Graham Juan | Mar 10, 2023 | Sell | 2,344 | $20.1973 | $47,000 |
| Graham Juan | Mar 10, 2023 | Sell | 1,456 | $20.1973 | $29,000 |
| Graham Juan | Mar 10, 2023 | Sell | 1,112 | $20.1973 | $22,000 |
| Wettig Thane | Mar 10, 2023 | Sell | 4,731 | $20.1973 | $96,000 |
| Wettig Thane | Mar 10, 2023 | Sell | 2,938 | $20.1973 | $59,000 |
| Conterno Enrique A | Mar 8, 2023 | Sell | 24,672 | $21.1559 | $520,000 |
| Chung Christine | Mar 8, 2023 | Sell | 8,354 | $21.1559 | $180,000 |
| Eisner Mark | Mar 8, 2023 | Sell | 7,363 | $21.1559 | $160,000 |
| Graham Juan | Mar 8, 2023 | Sell | 2,749 | $21.1559 | $58,000 |
| Wettig Thane | Mar 8, 2023 | Sell | 6,265 | $21.1559 | $130,000 |
| Eisner Mark | Mar 2, 2023 | Sell | 1,187 | $21.87 | $26,000 |
What's the latest insider transaction for FibroGen?
The most recent insider transaction for FibroGen was conducted by Adib Deyaa, who sold 22,123 shares on June 12, 2024 at a price of $1.17 per share.
Which insider bought the most FGEN stock over the last two years?
Wettig Thane has bought the most FGEN stock in the last 2 years, with a total value of $95,000.
Which insider has sold the most FGEN stock over the last two years?
Conterno Enrique A has sold the most FGEN stock in the last 2 years, with a total value of $1.4M.
What is the total value of insider transactions for FibroGen (FGEN) in the last 2 years?
The total value of insider transactions for FibroGen in the last 2 years is negative, amounting to -$4M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on FibroGen's market confidence?
Over the last 2 years, insider transactions for FibroGen have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
